pyridoxine has been researched along with n-(3-ethoxycarbonyloxirane-2-carbonyl)-isoleucyl-proline in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asao, T; Katunuma, N; Tsuge, H | 1 |
Katunuma, N | 1 |
2 review(s) available for pyridoxine and n-(3-ethoxycarbonyloxirane-2-carbonyl)-isoleucyl-proline
Article | Year |
---|---|
[Development of new specific inhibitors for cathepsins and its application for medical field].
Topics: Animals; Cathepsins; Crystallography, X-Ray; Dipeptides; Drug Design; Molecular Conformation; Propionates; Pyridoxine | 2000 |
[Structure-based drug development and medical/biological application of cathepsin specific inhibitors].
Topics: Antigen Presentation; Autoantigens; Bone Neoplasms; Cathepsins; Dipeptides; Drug Design; Epoxy Compounds; Humans; Lysosomes; Osteoporosis; Propionates; Protein Conformation; Pyridines; Pyridoxine; Receptor, Insulin; Sjogren's Syndrome | 2009 |